Showing results (921-930 of 3,081) with videos related to

Sort By:
Pageof 309
Drug Safety|April 12, 2019
Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor AgonistsRasmus M Christensen, Christian R Juhl, Signe S Torekov
Drug Safety|May 9, 2018
Safety of Tamsulosin: A Systematic Review of Randomized Trials with a Focus on Women and ChildrenSteven A Kaplan, Bilal I Chughtai
Drug Safety|May 26, 2018
Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future DirectionYlenia Ingrasciotta, Paola M Cutroneo, Ilaria Marcianò, et al.
Drug Safety|May 26, 2018
Correction to: Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid DependenceRoxanne Saucier, Daniel Wolfe, Nabarun Dasgupta
Drug Safety|October 21, 2021
Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design ApproachGeorge I Gavriilidis, Vlasios K Dimitriadis, Marie-Christine Jaulent, et al.
Drug Safety|October 26, 2021
Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case SeriesSamantha Cotter, Jennie Wong, Neha Gada, et al.
Drug Safety|October 8, 2021
The Effectiveness and Value of Written Medicine Information Across Asia and Africa: Systematic ReviewPitchaya Nualdaisri, Sarah A Corlett, Janet Krska
Drug Safety|July 20, 2022
Anti-tumor Necrosis Factor-Alpha Therapy and Hypoglycemia: A Real-World Pharmacovigilance AnalysisYu Zhou, Wenhuo Xie, Linyao Wang, et al.
Drug Safety|April 19, 2022
Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort StudyRichard L Morrow, Barbara Mintzes, Patrick C Souverein, et al.
Drug Safety|July 14, 2022
A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, John Horn, et al.
Pageof 309